Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of 7MW3711 versus docetaxel in previously treated advanced squamous non-small cell lung cancer
CTR20263442Phase 3Active
- Sponsor
- Maiwei Biotech
- Start
- Sep 2026
- Modality
- Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 7MW3711 in Pulmonary squamous cell carcinoma, sponsored by Maiwei Biotech. Started Sep 2026; status: active.
02
Drugs
7MW3711
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on CTR20263442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263442.